Inventor · disambiguated record
Robert N. Young
Also filed as: YOUNG ROBERT · YOUNG ROBERT A · YOUNG ROBERT N · YOUNG ROBERT NORMAN
66 granted patents·20 pending applications·929 citations·filing 1980–2025
99Inventor score
Files withMERCK FROSST CANADA INC38MERCK & CO INC9UNIV FRASER SIMON7BILLOT XAVIER5OSSIFI THERAPEUTICS LLC4
Top patents by PatentIndex Score
86 records- 0196US4661499A2-[(substituted)-phenoxymethyl]quinolinesMERCK FROSST CANADA INC·Filed 1985·Granted Apr 28, 1987·65 cites·7 claims
- 0295US11655250B2Pyrrolo-dipyridine compoundsOSTEOQC INC·Filed 2021·Granted May 23, 2023·4 cites·47 claims
- 0393US4918092ALeukotriene antagonistsMERCK FROSST CANADA INC·Filed 1988·Granted Apr 17, 1990·44 cites·7 claims
- 0491US10947236B2Pyrrolo-dipyridine compoundsOSTEOQC INC·Filed 2019·Granted Mar 16, 2021·4 cites·28 claims
- 0591US6034089AAryl thiophene derivatives as PDE IV inhibitorsMERCK FROSST CANADA INC·Filed 1998·Granted Mar 7, 2000·72 cites·11 claims
- 0690US4962117AHeterazole dialkanoic acidsMERCK FROSST CANADA INC·Filed 1988·Granted Oct 9, 1990·32 cites·12 claims
- 0790US4851409A2-substituted quinoline dioic acids and pharmaceutical compositionsMERCK FROSST CANADA INC·Filed 1987·Granted Jul 25, 1989·30 cites·9 claims
- 0889USD866581SDisplay panel with icons for a controllerRELIANCE MEDICAL PRODUCTS·Filed 2018·Granted Nov 12, 2019·37 cites·1 claims
- 0987US7199154B2Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitorsMERCK FROSST COMPANY·Filed 2003·Granted Apr 3, 2007·42 cites·18 claims
- 1087US6020339AAryl furan derivatives as PDE IV inhibitorsMERCK & CO INC·Filed 1998·Granted Feb 1, 2000·86 cites·9 claims
- 1187US4617407ALeukotriene antagonistsMERCK FROSST CANADA INC·Filed 1984·Granted Oct 14, 1986·17 cites·3 claims
- 1285US5409911AProstaglandin analog for treating osteoporosisMERCK & CO INC·Filed 1992·Granted Apr 25, 1995·55 cites·13 claims
- 1384US9650414B1Dual-action EP4 agonist—bisphosphonate conjugates and uses thereofUNIV FRASER SIMON·Filed 2015·Granted May 16, 2017·4 cites·17 claims
- 1484US5391044ALifting and towing apparatusFiled 1993·Granted Feb 21, 1995·49 cites·11 claims
- 1584US2025304584A1Pyrrolo - dipyridine compoundsOSSIFI THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 1683US12195461B2Pyrrolo-dipyridine compoundsOSSIFI THERAPEUTICS LLC·Filed 2023·Granted Jan 14, 2025·0 cites·23 claims
- 1783US7238710B2EP4 receptor agonist, compositions and methods thereofMERCK FROSST CANADA LTD·Filed 2005·Granted Jul 3, 2007·5 cites·11 claims
- 1882US12324809B2Fluoro beta-carboline compoundsOSSIFI THERAPEUTICS LLC·Filed 2024·Granted Jun 10, 2025·0 cites·20 claims
- 1982US11903949B2Fluoro beta-carboline compoundsOSSIFI THERAPEUTICS LLC·Filed 2019·Granted Feb 20, 2024·1 cites·17 claims
- 2082US5232916AQuinoline ether alkanoic acidsMERCK FROSST CANADA INC·Filed 1991·Granted Aug 3, 1993·24 cites·2 claims
- 2182US4609744A4-oxo-benzopyran carboxylic acidsMERCK FROSST CANADA INC·Filed 1984·Granted Sep 2, 1986·17 cites·5 claims
- 2280US10633338B2Binding Function 3 (BF3) site compounds as therapeutics and methods for their useUNIV BRITISH COLUMBIA·Filed 2019·Granted Apr 28, 2020·1 cites·16 claims
- 2380US6777433B2Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonatesMERCK FROSST CANADA INC·Filed 2002·Granted Aug 17, 2004·12 cites·21 claims
- 2480US4957932ABenzoheterazolesMERCK FROSST CANADA INC·Filed 1987·Granted Sep 18, 1990·28 cites·13 claims
- 2579US6448429B1Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonatesMERCK FROSST CANADA INC·Filed 2000·Granted Sep 10, 2002·13 cites·28 claims
- 2679US4962203A2-substituted quinolines useful as leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1989·Granted Oct 9, 1990·14 cites·9 claims
- 2776US7053085B2EP4 receptor agonist, compositions and methods thereofMERCK & CO INC·Filed 2004·Granted May 30, 2006·7 cites·10 claims
- 2876US4332810AN-(Substituted)-2,5-ethano-8-hydroxy (or methoxy)-1,2,3,4,5,6-hexahydro-3 (or 4)-benzazocine centrally-acting analgesicsMERCK & CO INC·Filed 1981·Granted Jun 1, 1982·9 cites·14 claims
- 2975US6121253AProstaglandin conjugates for treating or preventing bone diseaseMERCK FROSST CANADA INC·Filed 1999·Granted Sep 19, 2000·36 cites·18 claims
- 3073USRE42562EEP4 receptor agonist, compositions and methods thereofMERCK FROSST CANADA·Filed 2007·Granted Jul 19, 2011·1 cites·20 claims
- 3173US5204358AHetaryl styryl quinolines as leukotriene inhibitorsMERCK FROSST CANADA INC·Filed 1992·Granted Apr 20, 1993·14 cites·8 claims
- 3271US7109223B2Oxazolidin-2-one and thiazolidin-2-one derivatives for use as EP4 receptor agonists in the treatment of glaucomaMERCK & CO INC·Filed 2003·Granted Sep 19, 2006·5 cites·7 claims
- 3371US5104882ADiarylstrylquinoline diacids and pharmaceutical compositions thereofMERCK FROSST CANADA INC·Filed 1990·Granted Apr 14, 1992·13 cites·9 claims
- 3470US6586457B2Methods for inhibiting bone resorptionMERCK & CO INC·Filed 2001·Granted Jul 1, 2003·8 cites·5 claims
- 3570US4683325ALeukotriene antagonistsMERCK FROSST CANADA INC·Filed 1984·Granted Jul 28, 1987·8 cites·12 claims
- 3669US10351527B2Binding function 3 (BF3) site compounds as therapeutics and methods for their useUNIV BRITISH COLUMBIA·Filed 2015·Granted Jul 16, 2019·1 cites·24 claims
- 3769US5102881AQuinoline ether alkanoic acidsMERCK FROSST CANADA INC·Filed 1989·Granted Apr 7, 1992·8 cites·7 claims
- 3865US5472964ADiaryl 5,6-fused heterocyclic acids as leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1994·Granted Dec 5, 1995·20 cites·6 claims
- 3964US9611284B2Prostaglandin-bisphosphonate conjugate compounds, methods of making same, and uses thereofUNIV FRASER SIMON·Filed 2012·Granted Apr 4, 2017·2 cites·10 claims
- 4064US2009258918A1EP4 receptor agonist, compositions and methods thereofBILLOT XAVIER·Filed 2009·Application pending·0 cites
- 4163US11312737B2Amide-linked EP4 agonist-bisphosphonate compounds and uses thereofUNIV FRASER SIMON·Filed 2019·Granted Apr 26, 2022·0 cites·19 claims
- 4263US5017583ALeukotriene antagonistsMERCK FROSST CANADA INC·Filed 1988·Granted May 21, 1991·6 cites·2 claims
- 4362US2021024464A1Binding function 3 (bf3) site compounds as therapeutics and methods for their useUNIV BRITISH COLUMBIA·Filed 2020·Application pending·0 cites
- 4461US5004743APyridyl styrene dialkanoic acids as anti-leukotriene agentsMERCK FROSST CANADA INC·Filed 1987·Granted Apr 2, 1991·10 cites·10 claims
- 4560US5281720APyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesisMERCK FROSST CANADA INC·Filed 1992·Granted Jan 25, 1994·7 cites·4 claims
- 4660US4983628ALeukotriene antagonistsMERCK FROSST CANADA INC·Filed 1989·Granted Jan 8, 1991·6 cites·9 claims
- 4760US4376779AN-(Substituted)-2-aza-2'-hydroxy-5,6-benzotricyclo[6.3.01,8.04,11 ] undecane centrally-acting analgesicsMERCK SHARP & DOHME·Filed 1981·Granted Mar 15, 1983·4 cites·13 claims
- 4858US6348572B1Ligands for phosphatase binding assayMERCK FROSST CANADA INC·Filed 1998·Granted Feb 19, 2002·12 cites·5 claims
- 4956US4767745AConjugates of leukotrienes with proteinsMERCK FROSST CANADA INC·Filed 1986·Granted Aug 30, 1988·12 cites·8 claims
- 5056US4334077AStereospecific sulfoxidation of dibenzo thiepinsMERCK & CO INC·Filed 1981·Granted Jun 8, 1982·3 cites·3 claims
Showing the top 50 of 86 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Robert N. Young files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →